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Introduction
Free-living ameba uncommonly infect the skin but can do so in both immunocompromised 
and immunocompetent patients (1, 2). Only a few genera of free-living ameba are 
recognized as human pathogens: Acanthamoeba, Naegleria, Balamuthia, and Sappinia. 
Exposure to these organisms is likely common due to their ubiquitous nature in the natural 
environment; however, clinically significant skin infection is quite rare. B. mandrillaris has a 
predilection for infection of the central facial skin and can also involve the central nervous 
system (CNS), leading to granulomatous amebic encephalitis (GAE), which is almost 
invariably fatal (1, 3–5). This report describes a patient with a large centrofacial cutaneous 
lesion due to B. mandrillaris infection, the diagnosis of which eluded dermatologists and 
dermatopathologists for over one year. (6–8)
Report of a Patient
A 91-year-old woman with a history of chronic obstructive pulmonary disease, hypertension, 
congestive heart failure, and monoclonal gammopathy of uncertain significance (MGUS) 
was referred to dermatology clinic for a non-healing, red plaque over her right cheek. She 
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denied trauma to the area and had not traveled out of the state of Washington in decades; 
there was no history of fresh-water swimming. The lesion began approximately one year 
prior as a skin-colored bump and progressively enlarged, gradually developing into an 
erythematous and markedly indurated (“rock-hard”) plaque (Figure 1). The patient 
underwent several biopsies, each with nonspecific pathologic findings of granulomatous 
dermatitis. Repeated cultures and histochemical stains were negative for atypical 
mycobacterial and fungal organisms. The slides from these biopsies were also reviewed at 
our institution and another referral center with a similar interpretation. Initially, 
granulomatous rosacea was the favored diagnosis, but the lesion continued to enlarge despite 
multiple treatment modalities including intra-lesional steroid injection, oral antibiotics, and 
electron beam therapy.
After failing to improve, the patient was referred to our institution a second time, and 
underwent a larger, incisional biopsy near the site of her previous biopsies. Additionally, 
previous histopathologic slides from prior punch biopsy specimens were reviewed a second 
time along with clinical photographs and clinical notes from the electronic medical record.
Hematoxylin-eosin-stained sections of the incisional biopsy specimen contained skin and 
subcutaneous fat. There was diffuse, non-caseating granulomatous inflammation involving 
the dermis and subcutaneous fat (Figure 2a). The overlying epidermis was thin, without 
other significant pathologic alteration. Some areas lacked granulomas, but instead showed a 
mixed inflammatory infiltrate comprising lymphocytes, mature plasma cells, as well as 
occasional eosinophils. Histochemical stains and PCR studies were negative for fungal and 
mycobacterial organisms. The key finding in routinely-stained histopathologic sections was 
the presence of rare cells with bubbly pale grey cytoplasm, small, perfectly round nuclei, and 
extremely large nucleoli occupying greater than one-half of the nuclear area imparting a 
targetoid appearance consistent with amebae (Figure 2b–d). In some organisms, the 
extremely large nucleolus could be readily mistaken for the entire nucleus, due to faintly 
staining-to-clear peripheral chromatin and inconspicuous nuclear membrane. These 
structures resembled histiocytes, but could be distinguished by careful morphologic 
examination (Table 1). The number of organisms exhibiting diagnostic morphologic features 
was sparse—approximately one diagnostic form per slide. Subsequent 
immunohistochemical staining highlighted many more organisms than could be appreciated 
in conventional sections. Retrospective analysis of the previous punch biopsies revealed the 
presence of scattered amebae in each of the specimens.
A formalin-fixed tissue block from one of the punch biopsy specimens was then sent to the 
Centers for Disease Control and Prevention (CDC) for further characterization by 
polymerase chain reaction (PCR) and immunohistochemical analysis. DNA extracted from 
the skin specimen was positive for B. mandrillaris, and the cells of interest were 
immunoreactive using a free-living ameba immunohistochemistry assay (known to detect 
both B. mandrillaris and Acanthamoeba spp.), but appropriately non-reactive with antibodies 
against Acanthamoeba spp. (Figure 3). The patient was immediately referred to the 
infectious disease service, and began a CDC-recommended course of multi-agent antibiotic 
therapy comprised of azithromycin 500 mg daily, fluconazole 400 mg daily, and sulfadiazine 
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1500 mg four times a day. A magnetic resonance imaging (MRI) study did not show 
evidence of central nervous system (CNS) involvement.
The patient remained on this three-drug regimen for 5 months without any notable side 
effects. Her plaques softened and the total area of involvement was significantly reduced; 
however, there were some areas of slow progression near the midline of her face. At this 
point a course of miltefosine 50 mg three times a day, supplied by the CDC, was added in an 
effort to better control her disease.
Unfortunately, less than two weeks later, the patient developed nausea, anorexia, decreased 
appetite, and lower extremity swelling, which are known side effects of miltefosine, thus 
prompting its discontinuation. She also developed acute renal failure requiring 
hospitalization and discontinuation of her sulfadiazine. Her kidney function ultimately 
returned to normal and she returned to her previous state of general health. Neither the 
miltefosine nor the sulfadiazine were re-initiated.
Currently she remains on a 2-drug regimen of azithromycin and fluconazole and is followed 
clinically by dermatology and infectious diseases every 3 months. Due to the patient’s age, 
overall medical condition, and the above-described severe adverse drug reactions, the goal of 
her current treatment regimen is now disease containment but not necessarily complete 
clinical clearance. She remains free of symptoms of CNS involvement.
Discussion
B. mandrillaris is one of just a few free-living ameba which cause human disease, along with 
Acanthamoeba spp., Naegleria fowleri, and Sappinia pedata (8). B. mandrillaris was first 
identified in 1986 within the brain of a mandrill that died of meningoencephalitis at the San 
Diego Zoo. Mandrills are primates of the Old World monkey family. Since 1986, 
approximately 150–200 cases of cutaneous and/or CNS infections in humans have been 
reported. B. mandrillaris is found worldwide, but the majority of reported cases appear to 
arise from Lima, Peru and the United States, mostly in California and Texas (6). Like other 
free-living amebae, B. mandrillaris organisms can complete their entire life cycle 
independent of a host organism (9). The major reservoir for the organism is soil; organisms 
have been isolated from garden soil, mud baths, and potted plants (10–13). The organism has 
also been identified in domestic water-based environments, including faucets, showerheads, 
and bathtubs (10, 14). Our patient has been an avid gardener, and garden soil is the 
suspected source of her exposure to this organism. Transmission of free-living ameba from 
the environment to hosts usually occurs via skin breakage or via the respiratory system (15). 
Alternate modes of infection reported in literature include organ transplantation (16). B. 
mandrillaris infection occurs in both immunocompromised and immunocompetent hosts, 
particularly children (1, 2, 17).
Cutaneous involvement alone is an unusual presentation of balamuthiasis in the United 
States where most cases do not have skin lesions at all (only GAE), and if skin lesions are 
present, they exist in combination with CNS manifestations (CDC unpublished data). This is 
in contrast to Peruvian cases, in which skin lesions precede CNS involvement (8). Cutaneous 
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balamuthiasis characteristically presents with painless swelling and skin redness; however, 
physical exam findings vary widely, including ulcers, indurated plaques, and polypoid/warty 
configurations, sometimes mimicking cutaneous neoplasms such as squamous cell 
carcinoma (8, 9, 18). B. mandrillaris has a predilection for skin of the central face and 
extremities, and lesions are usually solitary. Cutaneous disease typically has a subacute to 
chronic clinical course – month to years may pass before a definitive diagnosis is made. 
GAE has a prodromal phase with nonspecific neurologic signs (e.g., headache, fever, nausea, 
photophobia) lasting weeks to months followed by a rapidly progressive phase which may 
be heralded by seizures, focal sensory-motor deficits, or lethargy soon followed by coma and 
death in over 90% of the reported cases (2, 8). Given the rarity of amebic infections and 
nonspecific symptoms, clinical diagnosis of B. mandrillaris infection is frequently incorrect. 
Most likely, a significant proportion of cases go undiagnosed and unreported. Even when B. 
mandrillaris is clinically suspected, histopathologic and laboratory diagnosis can still be 
challenging. Serologic tests can detect circulating antibodies against ameba by ELISA, 
indirect immunofluorescence, and Western blot. In addition, direct immunofluorescence 
staining with rabbit anti-Balamuthia sera exists as well. Immunohistochemical assays 
targeting free-living amebae have also been developed. Recently, PCR assays using primers 
against mitochondrial rRNA gene regions specific for Balamuthia have been developed. Real 
time PCR assays can have exquisitely high sensitivity, with the capability of detecting as few 
as a single ameba per sample (9). Given the rarity of suspected B. mandrillaris infection, 
these tests are not widely available outside of a few reference laboratories such as CDC. 
Because the diagnosis is usually not suspected clinically, pathologists can have a pivotal role 
in facilitating timely diagnosis. The histopathologic inflammatory pattern is usually non-
caseating granulomatous inflammation or mixed inflammation. Usually, both trophozoites 
and cysts are present in tissue specimens. Nevertheless, recognition of the organisms is 
hindered by their sparse number relative to the extensive inflammation, as well as their 
resemblance to histiocytes. Cysts are round, 15–30 μm in diameter, have a thick outer wall, a 
bubbly cytoplasm with refractile granules, and an inconspicuous nucleus. They are easily 
mistaken for degenerating histiocytes. Trophozoites are round, oval, or irregular in shape and 
12–60 μm in diameter. Most are uninucleate and contain bubbly amphophilic cytoplasm. The 
most helpful findings are the small nuclei with distinctive morphology imparted by a 
perfectly round shape, an extremely large nucleolus—(the “karyosome”)—more than one 
half the diameter of the nucleus, and a thin or unapparent nuclear membrane. However, not 
all trophozoites have the characteristic nuclear features and if the nuclei of the trophozoites 
are not represented in the plane of section, the organisms will likely go unnoticed. Also, 
Balamuthia and Acanthamoeba trophozoites have similar morphology in histopathologic 
sections and distinction may be difficult. The presence of multiple nucleoli may favor 
Balamuthia trophozoites over Acanthamoeba (8) (Figure 2c). If the pathologist suspects 
amebic infection in biopsy specimens, immunohistochemical stains and molecular PCR 
assays can provide diagnostic confirmation and species identification.
For patients presenting with cutaneous lesions, the most feared complication is CNS 
involvement and development of GAE, which is fatal if untreated or if treatment is delayed 
to the advanced stages of the disease. Unfortunately, the majority of the reported GAE cases 
have been diagnosed at autopsy. Nevertheless, there are reports in which GAE has been 
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diagnosed early and successfully treated (19, 20). Therefore, early biopsy of skin lesions and 
correct histopathologic diagnosis before patients develop advanced CNS injury may be 
lifesaving in some cases.
Conclusion
This report serves to raise awareness of cutaneous lesions due to Balamuthia mandrillaris, a 
rare and potentially deadly infection when complicated by CNS involvement. Delayed 
diagnosis is typical due to the rarity of this disorder, its nonspecific clinical findings, and 
nonspecific histopathologic findings—with the exception of scattered organisms exhibiting 
subtle but characteristic morphologic features. When the diagnosis is clinically unsuspected, 
biopsy of skin lesions may provide the first and only avenue for timely diagnosis and early 
intervention. Thus, infection by B. mandrillaris and other pathogenic amebae should be 
included in the histopathologic differential diagnosis of granulomatous dermatitis, and 
dermatopathologists should be familiar with the appearance of these organisms in routinely 
stained histopathologic sections.
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Clinical appearance of an erythematous and indurated plaque on the right cheek. The lesion 
shown is approximately 1-year old.
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a. Non-caseating granulomatous inflammation and lymphoid aggregates involving the 
dermis and subcutaneous fat without epidermal abnormalities (hematoxylin-eosin, ×20).
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b. An amebic organism (arrow and inset) with pale-gray, bubbly cytoplasm, round nucleus, 
and prominent nucleolus, imparting a targetoid appearance in an area of chronic 
inflammation (hematoxylin-eosin, ×400).
c. An area of granulomatous inflammation with a binucleate ameba inside of a 
multinucleated histiocyte giant cell (arrow and inset)(hematoxylin-eosin, ×400).
d. Two amebae (arrows) with retraction artifact imparting a lacunar appearance on the right 
(hematoxylin-eosin, ×400).
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Immunohistochemical staining with a red chromogen highlights multiple amebae in the deep 
dermis with granular cytoplasmic immunoreactivity (inset)(anti-free living amebae pooled 
antibody,×40).
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Table 1
Morphologic comparison of B. mandrillaris trophozoites and histiocytes in H&E-stained sections
Trophozoites Foamy histiocytes Epithelioid histiocytes
Cytoplasm Bubbly, faint amphophilic Bubbly, colorless Solid, eosinophilic
Nucleus Small and perfectly round Oval-to-reniform Oval-to-reniform
Nuclear membrane Delicate-to-absent Thin Thin
Nucleolus Large, sometimes occupying nearly the entire nucleus Inconspicuous Inconspicuous
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